Friday | ||
---|---|---|
15:00 – 15:20 | Opening Ceremony Kerim Güler(Turkish Society of Internal Medicine) Alden Begic, Dr. Mevludin Mekic, Dr. Sekib Sokolovic (Clinical Center University of Sarajevo) |
|
15:20 – 16:00 | Session 1 Chairs: Vedat Hamuryudan, Sedat Kiraz |
|
15:20 – 15:40 | Management of Diabetes in Rheumatological Diseases | Kubilay Ükinç |
15:40 – 16:00 | Cardiovascular manifestations in the rheumatic disorders | Sekib Sokolovic |
16:00 – 17:00 | Session 2 Chairs: İhsan Ertenli, Alden Begic |
|
16:00 – 16:20 | What ACR Really Recommends with the 2021 RA Treatment Guideline in Contrast to 2019 EULAR | İsmail Sarı |
16:20 – 16:40 | Can We Reach Comprehensive Disease Control in Rheumatoid Arthritis? | Cemal Bes |
16:40 – 17:00 | Managing Extra-Articular Manifestations in Rheumatoid Arthritis | Atalay Dogru |
17:00 – 17:20 | Anticoagulation in Autoimmune Rheumatic Diseases | Edin Begic |
17:20 – 17:40 | COFFEE BREAK | |
17:40 – 18:40 | Session 3 Chairs: Süleyman Serdar Koca, Bünyamin Kısacık |
|
17:40 – 18:00 | The relationships between cancer and autoimmune rheumatic diseases – how to treat? | Timur Ceric |
18:00 – 18:20 | Non-Radiographic Axial SpA: A Women’s Disease? | Selda Çelik |
18:20 – 18:40 | Is There a New Role for DMARDS and NSAIDs in the Treatment of Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis? | Nilay Şahin |
18:40 – 19:10 | Session 4: Oral Poster Presentations 1 Chair: Ozan Volkan Yurdakul, Amra Adrovic |
|
18:40 – 19:10 | Effect of BMI on Overall Survival and Time to Progression and Association of the Prognostic Factors: In HER2 Positive Metastatic Breast Cancer Patients Who Are Treated with Trastuzumab Aydan Köken Avşar Potential Relationship Between Helicobacter Pylori and Pancreatic Cancer Fatih Sarıtaş Mixed Cryoglobulinemia Caused by Brucellosis: A Case Report Özlem Kudaş AAV Patients with Renal İnvolvement: Single Center Experience Emrah Koç |
|
Saturday | ||
09:00 – 10:20 | Session 5 Chairs: Mevludin Mekic, Serdal Uğurlu |
|
09:00 – 09:20 | Renal failure in rheumatic diseases | Damir Rebic |
09:20 – 09:40 | How To Treat Vascular Involvement in Behçet’s Disease | Mehmet Engin Tezcan |
09:40 – 10:00 | How to Treat Intestinal Manifestations of Behçet’s Disease | Elif Sarıtaş Yuksel |
10:00 – 10:20 | Treatment of Behçet’s Disease Related Non-Infectious Uveitis | Murat Hasanreisoğlu |
10:20 – 11:20 | Session 6 Chairs: Alen Dzubur, Yusuf Ziya Erzin |
|
10:20 – 10:40 | How to Manage Uveitis in SpA? | Selçuk Sızmaz |
10:40 – 11:00 | How to Manage Gastrointestinal Manifestations of SpA | Tarkan Karakan |
11:00 – 11:20 | Can We Prevent the Transition from Psoriasis to PsA? | Pınar Talu Erten |
11:20 – 11:40 | COFFEE BREAK | |
11:40 – 12:40 | Session 7 Chairs: Meltem Melikoğlu, Akın Erdal |
|
11:40 – 12:00 | Safety Update for Biologics | Timur Pırıldar |
12:00 – 12:20 | Biologics in Bosnia and Herzegovina | Samir Mehmedagic |
12:20 – 12:40 | Management of ANCA Associated Vasculitis | Ali Taylan |
12:40 – 14:00 | Lunch | |
14:00 – 15:00 | Session 8 Chairs: Nermir Granov, Tufan Tükek |
|
14:00 – 14:20 | COVID-19 Pandemia: Where we are now? | Serhat Ünal |
14:20 – 14:40 | Biological Therapy in Arthritis Patients with Hepatitis B or C Infection | Duygu Tecer |
14:40 – 15:00 | Echocardiography in rheumatism | Azra Durak Nalbantic |
15:00 – 16:00 | Session 9 Chairs: Göksal Keskin, Süleyman Özbek |
|
15:00 – 15:20 | Patient with systemic disase as a patient for cardiac surgery -what we have to know? | Nermir Granov |
15:20 – 15:40 | Emerging Therapies in Psoriatic Arthritis | Duygu Ersözlü |
15:40 – 16:00 | Emerging Therapies in Ankylosing Spondylitis | Şükran Erten |
16:00 – 16:20 | COFFEE BREAK | |
16:20 – 17:20 | Session 10 Chairs: Taşkın Şentürk, Veli Yazısız |
|
16:20 – 16:40 | Role of Ultrasonography in the Diagnosis of Rheumatic Diseases in Light of ACR/EULAR Guidelines | Ayten Yazıcı |
16:40 – 17:00 | MRI for Diagnosis of Axial Spondyloarthritis: Major Advance with Critical Limitations | Ömer Karadağ |
17:00 – 17:20 | GLP1 agonists – is there benefit for patient with systemic disease? | Bosanko Horozic |
17:20 – 18:20 | Session 11: Oral Poster Presentations 2 Chair: Adem Küçük, Ahmet Omma |
|
17:20 – 18:20 | Case Report: Patient with Hypertrophic Osteoarthropathy. İsmail Uçar Association of Familial Mediterranean Fever (FMF)-Polyarteritis Nodosa (PAN) Presenting with Perirenal Hematoma Ali Nail Demir The Determination of Serum Adropine Level According to Concentration Levels of Hba1c İn Patients with Type 2 Diabetes Mellitus Fatih Albayrak Ankylosing Spondylitis Presenting with Acute Transverse Myelitis Nurçe Yavuz MINOCA in patient with Churg-Strauss syndrome
|
|
Sunday | ||
09:00 – 10:00 | Session 12 Chairs: Sedat Kiraz, Ömer Kuru |
|
09:00 – 09:20 | Colhicin is a drug of choice in post-Covid-19 | Sekib Sokolovic |
09:20 – 09:40 | Does Interleukin-23 (IL-23) Inhibitors Change the Course of Treatment in Psoriasis and Psoriatic Arthritis? | Umut Kalyoncu |
09:40 – 10:00 | When to Escalate and Taper the Biologics? | Fulya Coşan |
10:00 – 10:20 | COFFEE BREAK | |
10:20 – 11:20 | Session 13 Chairs: Alen Dzubur, Fatoş Önen |
|
10:20 – 10:40 | Update on the Management of Colchicine Resistant Familial Mediterranean Fever | Kemal Erol |
10:40 – 11:00 | EULAR Recommendations for the Management of Systemic Lupus Erythematosus | Emel Gönüllü |
11:00 – 11:20 | Prevention and Treatment of Glucocorticoid-Induced Osteoporosis | İlker Yağcı |
11:20 – 12:20 | Session 14: Oral Poster Presentations 3 Chair: Gezmiş Kimyon, Levent Kılıc |
|
11:20 – 12:20 | Evaluating The Effect of Covid-19 In Patients Diagnosed with Inflammatory Bowel Disease: A Single Center Experience Koray Koçhan Weekly Adalimumab Experience in Inflammatory Bowel Disease: A Single Center Experience Sezgin Barutçu Frequency of Helicobacter Pylori in Patients with Rheumatoid Arthritis Whose Methotrexate Was Stopped Due to Gastrointestinal Intolerance Emine Gözde Aydemir Gülöksüz Amebic Colitis Presented with Sacroiliitis Hasan Satış |